Council of Scientific and Industrial Research

Suchi Srivastava

Sushil Kumar

Suman Preet Singh Khanuja

Mahendra Pandurang Darokar

Tiruppadiripuliyur Ranganathan Santha Kumar

Ajit Kumar Shasany

Dharmendra Saikia

Nirmal Kumar Patra

Dharam Chand Jain

Sunita Dhawan

Krishna Kumar Agarwal

Ajit Kumar Shasney

Prachi Sinha

Ateeque Ahmed

Madan Mohan Gupta

Janak Raj Bahl

Ram Prakash Sharma

Sanjay Rai Kumar

Raj Kishori Lal

Asish Kumar Bhattacharya

Monika Singh

Digvijay Singh

Raghvendra Kumar Mishra

Suman Preet Khanuja

Preeti Chand

Arvind Kumar Tripathy

Tiruppadiripuliyur Ranganathan Kumar

Shashi Pandey Rai

The present invention relates to an alpha-arteether resistance domain (ADR) of Sequence ID No.1 and a method of identifying ADR in alpha-arteether resistant pathogens and lastly, it relates to set three pairs of primers of sequence ID Nos. 3 to 8.

Alpha arteether resistance domain

The present invention relates to the development of a unique inflorescence bearing mutant plant type lli/lli (LEAF-LESS INFLORESCENCE). Further the present invention relates to the development of a unique inflorescence bearing mutant plant type lli/lli (LEAF-LESS INFLORESCENCE) through chemical mutagenesis. The present invention relates to the development of a new and distinct plant type for floricultural usage. The new type is a monogenic Mendelian recessive stable mutant plant ofwith a novel leafless inflorescence architecture with increased flower frequency. This distinct plant ofwas developed through chemical mutagenesis followed by salt tolerance selection.

Plant variety of catharanthus roseus named 'lli'

The present invention relates to a rapid, sensitive, simple, and cost-effective spectrophotometric method of detecting and quantifying mycolic acid in a mycolic acid-fuschin dye complex with absorbance maxima ranging between 490-500 nm in the presence of various test compounds, for screening mycolic acid biosynthesis inhibitors useful as anti-microbial agents and a diagnostic kit thereof comprising basic fuschin dye in the concentration ranging between 0.1-1.0 gm/100 ml, phenol and 95% ethanol in the ratio ranging between 1:4 to 2:1 (v/v), and phenol and distilled water in the ratio ranging between 1:14 to 1:25.

Quick and sensitive method of quantifying mycolic acid to develop anti-microbial agents and a diagnostic kit thereof

A formulation useful in the treatment of drug resistant bacterial infections comprising an effective amount of thymol obtained from the plant , mint oil containing an appropriate amount of monoterpenes obtained from a hybrid of and , and conventional additives. A method for producing the formulation by mixing the above ingredients and a method for the treatment of drug resistance in a patient by administration of a therapeutically effective amount of the formulation.

Formulation comprising thymol useful in the treatment of drug resistant bacterial infections

The present invention relates a hexane bioactive fraction and obtained from the roots of an aromatic plant named commonly found in India for inhibiting the growth of drug resistant bacterial infections in humans and animals; also relates to a pharmaceutical composition comprising the bioactive extract with other additives for inhibiting the growth of drug resistant bacterial infections in humans and animals and a process for the isolation of said bioactive extract

Bioactive hexane fraction from Vetiveria zizanioides

A formulation useful in the treatment of drug resistant bacterial infections comprising an effective amount of thymol obtained from the plant mint oil containing an appropriate amount of monoterpenes obtained from a hybrid of and and conventional additives. A method for producing the formulation by mixing the above ingredients and a method for the treatment of drug resistance in a patient by administration of a therapeutically effective amount of the formulation.

This invention is related to the development of strategic and novel composition comprising &agr; arteether and nalidixic acid or quinolone drugs, said composition useful as an advanced generation drug to counter the resistance development itself and having a potential to be used in treating infectious diseases and in inhibiting the resistance developed due to mutation in the gyr A gene of bacteria, particularly in those cases where drug resistant strains are known to appear very frequently.

Anti-microbial composition and method for producing the same

The present invention relates to use .alpha.-arteether as a antibacterial agent, preferably for gyr mutant bacteria which are resistant to quinolone drugs and can be used as therapeutic agents for treating drug resistant bacterial infections, and also as a antifungal agent.

Method for the use of alpha arteether as an anti-bacterial and

Growing community of inventors

Lucknow, India

Suchi Srivastava